Zhi Qi
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine 6
-
- Cardiac Ischemia and Reperfusion 2
- Cancer Mechanisms and Therapy 1
-
- PARP inhibition in cancer therapy 3
- Drug Transport and Resistance Mechanisms 1
-
- Autophagy in Disease and Therapy 3
-
- FOXO transcription factor regulation 2
- Metabolism, Diabetes, and Cancer 2
- Co-authors
- Liang YangJie LiuYanna ShenQiong ZhangLei YangWencong TianLifeng FengYafei Li
- Journals
- PLoS ONE (1 paper)European Journal of Pharmacology (1 paper)Cell Death and Disease (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Zhi Qi
16 papers receiving 325 citations
Peers
Comparison fields: 5 of 80
- Geriatrics and Gerontology 62
- Physiology 14
- Pathology and Forensic Medicine 50
- Cardiology and Cardiovascular Medicine 59
- Oncology 64
Countries citing papers authored by Zhi Qi
This map shows the geographic impact of Zhi Qi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Qi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Qi more than expected).
Fields of papers citing papers by Zhi Qi
This network shows the impact of papers produced by Zhi Qi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Qi. The network helps show where Zhi Qi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhi Qi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2024 | 18 | |
| 4 | 2024 | 2 | |
| 5 | 2022 | 3 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 21 | |
| 8 | 2020 | 34 | |
| 9 | 2020 | 10 | |
| 10 | 2020 | 30 | |
| 11 | 2019 | 48 | |
| 12 | 2018 | 58 | |
| 13 | 2016 | 31 | |
| 14 | 2014 | 23 | |
| 15 | 2014 | 38 | |
| 16 | 2011 | 3 | |
| 17 | 2007 | 2 |
About Zhi Qi
Zhi Qi is a scholar working on Geriatrics and Gerontology, Aging and Biological Psychiatry, having authored 17 papers that have together received 330 indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (6 papers), Autophagy in Disease and Therapy (3 papers), PARP inhibition in cancer therapy (3 papers), FOXO transcription factor regulation (2 papers), Cardiac Ischemia and Reperfusion (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Cancer Mechanisms and Therapy (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Geriatrics and Gerontology (62 citations), Physiology (14 citations) and Pathology and Forensic Medicine (50 citations). Zhi Qi has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Liang Yang, Jie Liu, Yanna Shen, Qiong Zhang, Lei Yang, Wencong Tian, Lifeng Feng, Yafei Li, Jiling Ren and Fei Liu. Their work appears in journals such as PLoS ONE, European Journal of Pharmacology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.